Charles J. Dockendorff - May 7, 2024 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
Director
Signature
/s/ Susan Thompson, Attorney-in-Fact
Stock symbol
BSX
Transactions as of
May 7, 2024
Transactions value $
-$286,874
Form type
4
Date filed
5/8/2024, 04:11 PM
Previous filing
Mar 26, 2024
Next filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Sale -$287K -3.95K -100% $72.70 0 May 7, 2024 Direct F1
holding BSX Common Stock 42.6K May 7, 2024 By Spouse's Trust
holding BSX Common Stock 17.4K May 7, 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 19, 2023.